新诊断多发性骨髓瘤管理:梅奥骨髓瘤分层与风险调适治疗共识指南更新(2009版)

2009-11-01 梅奥诊所 Mayo Clin Proc. 2009;84(12):1095–1110

中文标题:

新诊断多发性骨髓瘤管理:梅奥骨髓瘤分层与风险调适治疗共识指南更新(2009版)

英文标题:

Management of Newly Diagnosed Symptomatic Multiple Myeloma:Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2009

发布机构:

梅奥诊所

发布日期:

2009-11-01

简要介绍:

Multiple myeloma is a malignant plasma cell neoplasm that affectsmore than 20,000 people each year and is the secondmost common hematologic malignancy. It is part of a spectrumof monoclonal plasma cell disorders, many of which do not requireactive therapy. During the past decade, considerable progresshas been made in our understanding of the disease processand factors that influence outcome, along with development ofnew drugs that are highly effective in controlling the disease andprolonging survival without compromising quality of life. Identificationof well-defined and reproducible prognostic factors andintroduction of new therapies with unique modes of action andimpact on disease outcome have for the first time opened up theopportunity to develop risk-adapted strategies for managing thisdisease. Although these risk-adapted strategies have not beenprospectively validated, enough evidence can be gathered fromexisting randomized trials, subgroup analyses, and retrospectivestudies to develop a working framework. This set of recommendationsrepresents such an effort—the development of a set ofconsensus guidelines by a group of experts to manage patientswith newly diagnosed disease based on an interpretation of thebest available evidence.

下载附件:

(需要扣积分10分)

版权声明:
本网站所有注明来源:“梅斯医学”或“MedSci”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:梅斯医学”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言